about
Genetic manipulation for inherited neurodegenerative diseases: myth or reality?High throughput microplate respiratory measurements using minimal quantities of isolated mitochondriaChildhood mitochondrial encephalomyopathies: clinical course, diagnosis, neuroimaging findings, mtDNA mutations and outcome in six children.Inhibition of ATPIF1 ameliorates severe mitochondrial respiratory chain dysfunction in mammalian cells.RNF185, a novel mitochondrial ubiquitin E3 ligase, regulates autophagy through interaction with BNIP1.Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.In vivo quantification reveals extensive natural variation in mitochondrial form and function in Caenorhabditis briggsae.Ketogenic diets: from cancer to mitochondrial diseases and beyond.Mitochondrial protein sorting as a therapeutic target for ATP synthase disorders.The impact of mitochondrial function/dysfunction on IVF and new treatment possibilities for infertility.Melatonin in mitochondrial dysfunction and related disordersContext-Dependent Role of Mitochondrial Fusion-Fission in Clonal Expansion of mtDNA MutationsYeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.The therapeutic potential of mitochondrial channels in cancer, ischemia-reperfusion injury, and neurodegeneration.Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice.Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress.Deletion of conserved protein phosphatases reverses defects associated with mitochondrial DNA damage in Saccharomyces cerevisiaeTurn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.Energy matters: mitochondrial proteomics for biomedicine.Pathogenesis and treatment of mitochondrial myopathies: recent advances.Is metabolic stress a common denominator in inflammatory bowel disease?Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.Consequences of oxidative stress in age-related macular degeneration.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Manipulating mitochondrial genomes in the clinic: playing by different rules.Invertebrate models for coenzyme q10 deficiency.Protective role of melatonin in mitochondrial dysfunction and related disorders.Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?Cardiomyocytes are Protected from Antiretroviral Nucleoside Analog-Induced Mitochondrial Toxicity by Overexpression of PGC-1α.Human mitochondrial nucleases.Biochemical Assessment of Coenzyme Q10 Deficiency.Rotenone-induced death of RGC-5 cells is caspase independent, involves the JNK and p38 pathways and is attenuated by specific green tea flavonoids.Molecular analysis of mitochondrial compromise in rodent cardiomyocytes exposed long term to nucleoside reverse transcriptase inhibitors (NRTIs).A mitochondrially targeted compound delays aging in yeast through a mechanism linking mitochondrial membrane lipid metabolism to mitochondrial redox biology.Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?Mitochondrial membrane lipidome defines yeast longevity.Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.Early life benefits and later life costs of a two amino acid deletion in Drosophila simulans.Mitochondrial fission proteins Fis1 and Mdv1, but not Dnm1, play a role in maintenance of heteroplasmy in budding yeast
P2860
Q26752831-BEBFC928-5964-431B-B29E-48821E302322Q28479257-642325E9-2422-40CD-8C99-55D009441EB9Q31140230-72A60DB8-9AF3-4219-8C56-3EF286F90E09Q33696265-6EDE4404-F3A8-4A58-9D1D-54D90A45D12AQ34023438-17883E60-86A9-48E6-9E9B-7BF398D3AF76Q34152110-1C2EF450-65F0-45BE-ABF0-1370A5E58B35Q34405677-DD16E391-0984-4FF7-B761-60A144F7FEA4Q34509699-98575E44-E347-4DCD-9FCC-D2E4BED7EBDFQ34836208-C01BDB1B-4959-46AE-8806-A0CCA64F09EBQ34979054-E581330C-566A-4049-9D5D-8429DB449D31Q35001051-5FD4CD80-325C-437F-ACE7-3B5DC1CC40EDQ35634191-66CB5B02-EF50-4297-9732-3F1701972BFAQ35687142-8BC96327-2F65-4B3F-88AE-509E7921A2C5Q35893619-652E3185-4340-4819-A344-1AA382F19210Q36135714-F9A81B7F-CF2E-4310-A728-BAE598AD42B8Q36207366-1AE81D99-6EB9-4D55-893C-982A2F633A42Q37369860-00292159-DA45-4098-A908-1A74EA0DF131Q37543961-E1B705E5-FF23-452A-B2B9-E1DF24EC460DQ37686240-06687AD9-339C-4D14-A8C8-740A2D1824B2Q37829412-C4A69451-27C5-46B5-B71D-1BA8753A009CQ37840050-56A806D5-0964-4AFE-8FD5-E36BCC3BC64BQ37914788-85E9DB11-F286-40C7-BD92-69CDAA16F47EQ37923355-AB7149E7-ECAD-40BD-8F7C-9115EFEB8FFCQ38003229-70E16AB0-5D1D-4A24-9CBD-9BA5BDE883FCQ38086474-40638BAE-CEDA-4834-BF70-E0186791D967Q38200226-06B8D40D-D21B-4A1D-8CC5-B025646247ADQ38240141-718F9DE3-1981-4C7A-8F17-10C946D10C27Q38359199-B2EC962F-5611-4EC4-9D18-326610A278D8Q38649157-F0586033-A0FB-49F6-9795-FE6F75DA4DF8Q38942113-677B6E1D-DCD1-4EAA-8086-C1808A82C56EQ39031724-3E0B3352-6139-4AC8-BD4C-A9C3E98B2AF1Q39168844-B7680C24-6367-4DE2-9084-18DE2FE23D4DQ39393378-43A800F4-84E7-4C77-9331-4B5A95B6FB6FQ39428374-421BEB75-B47D-4B42-9854-F5B5B028CA0EQ41959039-06856929-7DAA-4926-8117-B2D156DBC945Q42132131-5C650E37-F19E-4B2A-99B8-D8B706D844C9Q42589419-E9BC3BCA-1DFC-42D0-AC3C-F08611C7F6C0Q46290321-0DC53CE0-43A1-4C34-A4A7-8A8D96E38A4BQ52712869-4B33A5AC-3D41-4917-B6DD-06C36800F9CCQ57228535-577E4EE5-887B-49D0-9807-88E207ABAEB9
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic prospects for mitochondrial disease.
@ast
Therapeutic prospects for mitochondrial disease.
@en
Therapeutic prospects for mitochondrial disease.
@nl
type
label
Therapeutic prospects for mitochondrial disease.
@ast
Therapeutic prospects for mitochondrial disease.
@en
Therapeutic prospects for mitochondrial disease.
@nl
prefLabel
Therapeutic prospects for mitochondrial disease.
@ast
Therapeutic prospects for mitochondrial disease.
@en
Therapeutic prospects for mitochondrial disease.
@nl
P2093
P2860
P1476
Therapeutic prospects for mitochondrial disease.
@en
P2093
Eric A Schon
Michio Hirano
Robert W Gilkerson
P2860
P304
P356
10.1016/J.MOLMED.2010.04.007
P577
2010-06-01T00:00:00Z